Athira Pharma, Inc.Athira Pharma, Inc.Athira Pharma, Inc.

Athira Pharma, Inc.

No trades
See on Supercharts

Price target

0.620.000.00%
The 3 analysts offering 1 year price forecasts for ATHA have a max estimate of — and a min estimate of —.

Analyst rating

Based on 5 analysts giving stock ratings to ATHA in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


ATHA EPS for the last quarter is −0.75 USD despite the estimation of −0.70 USD. In the next quarter EPS is expected to reach −0.45 USD. Track more of Athira Pharma, Inc. financials and stay on top of what is up with the company.
In the next quarter Athira Pharma, Inc. revenue is expected to reach 0.00 USD. Check out Athira Pharma, Inc. revenue and earnings and make informed decisions.
According to analysts, ATHA price target is 0.62 USD with a max estimate of 0.75 USD and a min estimate of 0.50 USD. Check if this forecast comes true in a year, meanwhile watch Athira Pharma, Inc. stock price chart and keep track of the current situation with ATHA news and stock market news.
We've gathered opinions of 5 analysts rating ATHA stock in the past 3 months. Most of them backed up the neutral trend, and after taking into account other opinions, the overall rating was calculated as neutral. Note that it's not a trading advice — your own analysis is still required.